Laporan Laba Rugi EQL - TTM - EQL Pharma AB (publ)

Laporan Laba Rugi (TTM)

Laporan Laba Rugi EQL Pharma AB (publ) menunjukkan perubahan pendapatan dan pengeluaran selama periode waktu tertentu. Data Laporan Laba Rugi meliputi Penjualan dan Pendapatan, Laba Kotor, Penelitian dan Pengembangan (R&D), Beban Penjualan, Umum dan Administrasi (SG&A), Laba Operasi, Beban Pajak Penghasilan, Beban Bunga, Pendapatan Non-Operasi, Laba per Saham (EPS), dan Saham yang Beredar.

Semua angka adalah kelipatan 1,000,000 kecuali unit per saham.

	2020 09-30	2020 12-31	2021 03-31	2021 06-30	2021 09-30	2021 12-31	2022 03-31	2022 06-30	2022 09-30	2022 12-31	2023 06-30	2023 09-30	2023 12-31	2024 03-31	2024 06-30	2024 09-30	2024 12-31	2025 03-31	2025 06-30
Revenue	163	172	179	117	145	233	410	419	440	403	270	256	246	264	291	316	338	374	398
Change (%)		5.31	4.09	-34.73	23.61	60.88	76.22	2.15	5.13	-8.50	-32.93	-5.06	-3.89	7.23	10.06	8.82	6.96	10.38	6.54
% of Revenue	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00

Cost Of Sales	109	117	128	72	95	161	314	315	324	283	152	143	135	149	165	180	197	218	233
Change (%)		6.85	9.86	-43.57	30.91	69.74	95.44	0.35	2.72	-12.48	-46.46	-5.93	-5.61	10.73	10.59	8.98	9.89	10.16	7.01
% of Revenue	66.80	67.77	71.53	61.84	65.49	69.10	76.64	75.29	73.56	70.36	56.18	55.66	54.67	56.45	56.72	56.81	58.36	58.25	58.51

Gross Operating Profit	54	55	51	45	50	72	96	103	116	119	118	114	112	115	126	137	141	156	165
Change (%)		2.20	-8.03	-12.51	11.77	44.07	33.22	8.05	12.46	2.56	-0.82	-3.95	-1.73	3.00	9.38	8.60	3.10	10.69	5.88
% of Revenue	33.20	32.23	28.47	38.16	34.51	30.90	23.36	24.71	26.44	29.64	43.82	44.34	45.33	43.55	43.28	43.19	41.64	41.75	41.49

SG&A	32	32	28	31	34	41	48	51	56	59	63	64	68	71	74	77	78	78	83
Change (%)		-0.58	-10.80	7.86	11.56	21.55	16.36	6.11	9.03	5.98	7.02	1.50	5.43	4.71	4.33	4.30	0.60	1.23	5.86
% of Revenue	19.52	18.43	15.80	26.10	23.56	17.80	11.75	12.21	12.66	14.67	23.40	25.02	27.45	26.80	25.41	24.35	22.91	21.01	20.87

R&D	2	2	12	12	11	10	9	9	11	14	14	14	14	12	13	13	12	11	11
Change (%)		33.37	382.28	-0.47	-7.63	-8.87	-6.85	-0.68	25.25	18.93	4.52	-1.26	2.04	-15.02	8.80	-0.94	-9.78	-4.19	-3.33
% of Revenue	1.11	1.41	6.53	9.96	7.44	4.22	2.23	2.17	2.58	3.36	5.23	5.44	5.77	4.58	4.52	4.12	3.47	3.02	2.74

OpEx	145	153	168	114	139	211	371	375	390	355	229	220	216	232	251	269	286	306	325
Change (%)		5.44	9.54	-32.01	22.02	52.05	75.44	1.07	4.13	-8.95	-35.68	-3.64	-1.92	7.17	8.33	7.12	6.30	7.19	6.27
% of Revenue	88.80	88.91	93.57	97.46	96.21	90.92	90.52	89.57	88.72	88.29	84.67	85.94	87.70	87.65	86.27	84.93	84.41	81.96	81.76

Operating Income	18	19	12	3	5	21	39	44	50	47	41	36	30	33	40	48	53	67	73
Change (%)		4.23	-39.61	-74.23	84.57	285.16	84.01	12.45	13.67	-5.03	-12.21	-12.91	-15.97	7.65	22.39	19.46	10.67	27.66	7.76
% of Revenue	11.20	11.09	6.43	2.54	3.79	9.08	9.48	10.43	11.28	11.71	15.33	14.06	12.30	12.35	13.73	15.07	15.59	18.04	18.24

Interest Expense	-1	-1	-1	-1	-2	-2	-3	-3	-3	-2	-3	-3	-4	-6	-7	-8	-9	-12	-18
Change (%)		9.25	19.44	13.73	31.57	36.51	27.90	-2.02	0.21	-12.37	11.24	13.05	33.44	38.12	21.96	19.08	8.02	37.21	48.29
% of Revenue	-0.52	-0.54	-0.61	-1.07	-1.14	-0.97	-0.70	-0.67	-0.64	-0.61	-1.02	-1.21	-1.68	-2.17	-2.40	-2.63	-2.66	-3.30	-4.60

Net Income	16	17	10	2	4	19	32	36	39	33	30	28	22	23	26	31	35	43	43
Change (%)		4.36	-38.17	-83.95	127.16	397.51	67.76	15.51	5.79	-13.61	-8.86	-9.16	-19.73	2.58	15.80	18.57	11.40	24.17	-1.35
% of Revenue	9.83	9.74	5.79	1.42	2.62	8.09	7.70	8.71	8.76	8.27	11.24	10.76	8.98	8.59	9.04	9.85	10.26	11.55	10.69

Source: Capital IQ

EQL Pharma AB (publ) - Laporan Laba Rugi (TTM)

Laporan Laba Rugi (TTM)

Other Listings